4 free views remaining today
autosomal dominant intellectual developmental disorder 54
Description
Autosomal dominant intellectual developmental disorders are a group of conditions characterized by intellectual disability and impaired adaptive behavior, often with significant delays in speech and language development.
- Characteristics: These disorders are typically inherited in an autosomal dominant pattern, meaning that only one copy of the mutated gene is needed to cause the disease. They can be caused by mutations in various genes, leading to a range of symptoms and severity levels.
- Symptoms: The symptoms of autosomal dominant intellectual developmental disorders can vary widely among affected individuals, but often include:
- Mild to severe intellectual disability
- Delays in speech and language development
- Global developmental delay (GDD)
- Impaired adaptive behavior
- Autistic features in some cases
According to search results [1], Autosomal dominant intellectual developmental disorder-54 is characterized by mildly to severely impaired intellectual development with speech delays. This condition can be caused by mutations in various genes, leading to a range of symptoms and severity levels.
It's worth noting that the exact characteristics and symptoms of autosomal dominant intellectual developmental disorders can vary widely among affected individuals, and may depend on the specific gene mutation involved [7].
References: [1] - Search result 1 [7] - Search result 7
Additional Characteristics
- Autosomal dominant intellectual developmental disorders
- autistic features in some cases
- mildly to severely impaired intellectual development with speech delays
Signs and Symptoms
Based on the available information, here are the signs and symptoms associated with autosomal dominant intellectual developmental disorder 54 (MRD54):
- Global Developmental Delay: MRD54 is characterized by global developmental delay, which affects various aspects of development, including cognitive, motor, and language skills [1].
- Intellectual Disability: Individuals with MRD54 may experience impaired intellectual development, leading to mild to moderate intellectual disability or learning problems [2].
- Unique Personality Characteristics: People with MRD54 may exhibit unique personality characteristics, which can be a distinguishing feature of this condition [3].
It's worth noting that the severity and presentation of symptoms can vary among individuals with MRD54. Some people may experience more pronounced developmental delays, while others may have milder symptoms.
References: [1] - Characterized by global developmental delay (DD) and variable degrees of intellectual disability (ID) [2] - This condition is characterized by mild to moderate intellectual disability or learning problems [3] - May 31, 2022 — unique personality characteristics
Additional Symptoms
- Intellectual Disability
- Global Developmental Delay
- Unique Personality Characteristics
Diagnostic Tests
Autosomal dominant intellectual developmental disorder (ID) 54, also known as Intellectual Disability Autosomal Dominant 54, is a genetic condition characterized by significantly below-average general intellectual functioning associated with impairments in adaptive behavior.
Diagnostic tests for Autosomal Dominant ID 54:
- Chromosomal microarray analysis: This test can identify copy number variations (CNVs) and other chromosomal abnormalities that may contribute to the development of ID 54. [1]
- Exome sequencing: This test analyzes the protein-coding regions of the genome to identify genetic mutations associated with ID 54. [9]
- Karyotype analysis: This test examines the number and structure of chromosomes to detect any chromosomal abnormalities that may be contributing to the condition. [4]
- Metabolic testing: This test evaluates various metabolic pathways to rule out other conditions that may present with similar symptoms. [4]
Other diagnostic approaches:
- Genetic counseling: Genetic counselors can provide information and support to individuals and families affected by ID 54, as well as help identify potential genetic causes of the condition.
- Clinical evaluation: A comprehensive clinical evaluation by a qualified healthcare professional is essential for diagnosing ID 54. This involves assessing cognitive, adaptive, and behavioral functioning.
References:
[1] - Chromosomal microarray analysis can be used to detect copy number variations associated with intellectual disability. [Context #1] [4] - Karyotype analysis and metabolic testing may be used to rule out other conditions that present with similar symptoms. [Context #4] [9] - Exome sequencing can be used to identify genetic mutations associated with ID 54. [Context #9]
Please note that these diagnostic tests are not exhaustive, and the specific tests used may vary depending on individual circumstances. A qualified healthcare professional should be consulted for accurate diagnosis and guidance.
Additional Diagnostic Tests
- Metabolic testing
- Exome sequencing
- Karyotype analysis
- Chromosomal microarray analysis
Treatment
Based on the search results, it appears that there is limited information available on the drug treatment of autosomal dominant intellectual developmental disorder 54 (MRD54). However, I can provide some general information on the topic.
Current Research and Therapies
According to a review by Hou et al. [7], there are ongoing efforts to develop pharmacotherapeutic strategies for neurodevelopmental disorders, including intellectual developmental disorders. While specific treatments for MRD54 may not be mentioned in this review, it highlights the importance of translational research in developing effective therapies for these conditions.
Potential Therapies
A summary on autosomal dominant intellectual developmental disorder 43 (MRD43), which is caused by mutations in the HIVEP2 gene [13], mentions that there are ongoing efforts to develop treatments for this condition. Although MRD54 and MRD43 are distinct disorders, it is possible that some of these potential therapies may be explored for MRD54 as well.
Risperidone
A summary on intellectual developmental disorder with good [5] mentions risperidone as a treatment option for disruptive, aggressive, and self-injurious behaviors in children with intellectual developmental disorder. While this information is not specific to MRD54, it suggests that risperidone may be considered as a potential treatment for certain symptoms associated with intellectual developmental disorders.
Future Directions
Given the limited information available on drug treatment for MRD54, further research is needed to identify effective therapies for this condition. Ongoing studies and clinical trials may provide more insights into potential treatments for MRD54 in the future.
References:
[7] Hou et al. (2024) - This review provides an overview of the physiological basis of gene variations in ID and comprehensively describes the diagnosis and therapy of ID. [5] - Risperidone is mentioned as a treatment option for disruptive, aggressive, and self-injurious behaviors in children with intellectual developmental disorder.
Please note that these references are not specific to MRD54 but provide general information on intellectual developmental disorders.
Recommended Medications
- Ongoing efforts to develop pharmacotherapeutic strategies for neurodevelopmental disorders
- Potential therapies for autosomal dominant intellectual developmental disorder 43 (MRD43) may be explored for MRD54
- risperidone
- Risperidone
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
The differential diagnosis for autosomal dominant intellectual developmental disorder (MRD54) includes a range of conditions that can present with similar symptoms, such as intellectual disability and developmental delays.
- Other autosomal dominant disorders, including MRD6, MRD42, and others, should be considered in the differential diagnosis [1].
- Disorders associated with neurodevelopmental delay, seizure, obesity, and behavioral disturbances are also part of the differential diagnosis [2].
- Syndromic intellectual disability and developmental delays, such as those caused by chromosomal abnormalities or other genetic conditions, should be ruled out [3].
- Conditions that can cause prenatal and postnatal growth retardation, microcephaly, and other physical anomalies, such as autosomal recessive disorders, should also be considered in the differential diagnosis [4].
It's worth noting that a specific molecular diagnosis is often established after whole exome sequencing, which can help identify the underlying genetic cause of the disorder [5]. The prevalence of developmental disorders caused by de novo mutations is reported to be around 1/448 births, highlighting the importance of considering these conditions in the differential diagnosis [6].
References:
[1] Context result 3 [2] Context result 6 [3] Context result 4 [4] Context result 7 [5] Context result 12 [6] Context result 13
Additional Differential Diagnoses
- Other autosomal dominant disorders (MRD6, MRD42)
- Disorders associated with neurodevelopmental delay, seizure, obesity, and behavioral disturbances
- Syndromic intellectual disability and developmental delays caused by chromosomal abnormalities or other genetic conditions
- Autosomal recessive disorders causing prenatal and postnatal growth retardation, microcephaly, and physical anomalies
Additional Information
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:0080230
- core#notation
- DOID:0080230
- oboInOwl#hasDbXref
- MIM:617799
- IAO_0000115
- An autosomal dominant intellectual developmental disorder that has_material_basis_in heterozygous mutation in the CAMK2B gene on chromosome 7p13.
- rdf-schema#label
- autosomal dominant intellectual developmental disorder 54
- oboInOwl#hasExactSynonym
- autosomal dominant mental retardation 54
- rdf-schema#subClassOf
- http://purl.obolibrary.org/obo/DOID_0060307
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_2600
- owl#annotatedSource
- t353807
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.